Orlando Clinical Research Center   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Orlando United States (1990)

Organization Overview

First Clinical Trial
2005
NCT00127803
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Orlando Clincal Reserach Center | Orlando Clinical | Orlando Clinical Research | Orlando Clinical Research Center | Orlando Clinical Research Center, 5055 S Orange Avenue, Orlando, Florida, United States. | Orlando Clinical Research Center US | Orlando Clinical Research Centre, US

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Clostridium Infections (Phase 1)

Hepatic Encephalopathy (Phase 4)

Hepatic Insufficiency (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 2)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hypertension (Phase 1)

Kidney Failure, Chronic (Phase 2)

Liver Diseases (Phase 2)

Liver Failure (Phase 4)

Monkeypox (Phase 1)

Renal Insufficiency (Phase 1)

Renal Insufficiency, Chronic (Phase 1)

Smallpox (Phase 1)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 28
  • # of Trial APIs: 26